Dr. Sanjai Saxena
Professor
Biotechnology
Thapar Institute of Engineering and Technology
India
Biography
ACADEMIC PREPARATION Ph.D. Biological Sciences, spl. Fungal biotechnology Department of Biological Sciences, Rani Durgavati University (2000) M.Sc. Biological Sciences spl. Biotechnology, Department of Biological Sciences, Rani Durgavati University (1996) B.Sc. Hons. Botany, University of Delhi (1992) PROFESSIONAL SYNOPSIS Over 16 years of Leadership in the interface of Pharma and Biotechnology involving exploration and exploitation of novel biomolecules from different biological systems and their interaction in the nature. This actually involves development of screening platforms for different biological activities such as anti-microbial, anti- oxidant, anti-cancer or finding novel molecules which interfere in the mechanism of development of diseases such as Alzheimer's Dementia (AD), Parkinson's disease (PD), Obesity, Anti-gout/arthritic and type II Diabetes.
Research Interest
RESEARCH DOMAINS (Industrial/ Medicinal Biotech): Drug Discovery; plant-microbe interaction; cellular biochemistry and cell biology; microbial biochemistry; clinical microbiology; enzymology; Food security and Ethnopharmacology.
Publications
-
Vineet Meshram, Sanjai Saxena and Karan Paul (2016): Xylarinase: a novel clot busting enzyme from an endophytic fungus Xylaria curta. Journal of Enzyme Inhibition and Medicinal Chemistry 31 (6): 1502-1511
-
Alka Sharma, Vijay Luxami, Sanjai Saxena and Kamaldeep Paul (2016): Benzimidazole Based Quinazolines In Vitro Evaluation, Quantitative Structure–Activity Relationship, and Molecular Modeling as Aurora Kinase Inhibitors. Archiv der Pharmazie 349 (3): 193-201
-
Ramadeep Kaur Mehton, Vineet Meshram, Sanjai Saxena and Manmohan Chhibber (2016): Synthesis and Anti- Staphylococcal Activity of 2, 4-Disubstituted Diphenylamines. Journal of Brazilian Chemical Society 27(7): 1236- 1244
